Shenzhen Hepalink Pharmaceutical Group Co., Ltd.

Shenzhen Hepalink Pharmaceutical Group Co., Ltd.verified

002399.SZ

Price:

$11.7

Market Cap:

$14.59B

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. engages in the manufacture and sale of pharmaceutical products in Hong Kong, the United States, Europe, Mainland China, and internationally. The company operates through four segments: Finished dose pharmaceutical products, Active Pharmaceutical Ingredients (API), Contract Development and Manufacturing Organization, and Others. Its pharmaceutical products consist of finished dose pharmaceutical products, which primarily include enoxaparin sodium injection; API products, including heparin sodium API and enoxaparin sodium API; and other products, such as pancreatin API. The company is also involved in the provision of research and development, m...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2010-05-06

Stock Exchange

SHZ

Ticker

002399.SZ

The PE Ratio as of December 2025 (TTM) for Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (002399.SZ) is 40.34

According to Shenzhen Hepalink Pharmaceutical Group Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 40.34. This represents a change of 247.76% compared to the average of 11.60 of the last 4 quarters.

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (002399.SZ) Historical PE Ratio (quarterly & annually)

How has 002399.SZ PE Ratio performed in the past?

The mean historical PE Ratio of Shenzhen Hepalink Pharmaceutical Group Co., Ltd. over the last ten years is 42.58. The current 40.34 PE Ratio has changed 9.37% with respect to the historical average. Over the past ten years (40 quarters), 002399.SZ's PE Ratio was at its highest in in the June 2017 quarter at 387.22. The PE Ratio was at its lowest in in the March 2017 quarter at -537.37.

Quarterly (TTM)
Annual

Average

42.58

Median

36.67

Minimum

-22.01

Maximum

104.20

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (002399.SZ) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Shenzhen Hepalink Pharmaceutical Group Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 357.96%

Maximum Annual PE Ratio = 104.20

Minimum Annual Increase = -210.18%

Minimum Annual PE Ratio = -22.01

Quarterly (TTM)
Annual
YearPE RatioChange
202424.25-210.18%
2023-22.01-184.92%
202225.92-75.13%
2021104.20357.96%
202022.75-0.94%
201922.97-51.57%
201847.43-49.73%
201794.3463.87%
201657.5719.09%
201548.34-20.78%

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (002399.SZ) Average PE Ratio

How has 002399.SZ PE Ratio performed in the past?

The current PE Ratio of Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (002399.SZ) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

9.39

5-year avg

31.02

10-year avg

42.58

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (002399.SZ) PE Ratio vs. Peers

How is 002399.SZ’s PE Ratio compared to its peers?

Shenzhen Hepalink Pharmaceutical Group Co., Ltd.’s PE Ratio is greater than Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (23.02), less than Shanghai Haoyuan Chemexpress Co., Ltd. (50.86), greater than Zhejiang Jiuzhou Pharmaceutical Co., Ltd (21.94), greater than Apeloa Pharmaceutical Co.,Ltd (22.32), greater than Zhejiang Jingxin Pharmaceutical Co., Ltd. (22.12), greater than Pacific Shuanglin Bio-pharmacy Co., Ltd. (22.67), greater than Guangdong Zhongsheng Pharmaceutical Co., Ltd. (-82.33), less than Beijing Aosaikang Pharmaceutical Co., Ltd. (59.32), greater than Tibet Rhodiola Pharmaceutical Holding Co. (13.48), greater than Yifan Pharmaceutical Co., Ltd. (35.56),

Build a custom stock screener for Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (002399.SZ) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Shenzhen Hepalink Pharmaceutical Group Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (002399.SZ) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Shenzhen Hepalink Pharmaceutical Group Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Shenzhen Hepalink Pharmaceutical Group Co., Ltd.'s PE Ratio?

How is the PE Ratio calculated for Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (002399.SZ)?

What is the highest PE Ratio for Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (002399.SZ)?

What is the 3-year average PE Ratio for Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (002399.SZ)?

What is the 5-year average PE Ratio for Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (002399.SZ)?

How does the current PE Ratio for Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (002399.SZ) compare to its historical average?